Welcome to kongre.net
Speaker
Principal Investor, Newpath Partners
Tom Thomas, Principal Investor at Newpath Partners, is speaking at 4th Cell Therapy for Autoimmune Disease Summit 2026 (Philadelphia, United States of America, 1–3 Dec 2026) in the session “Audience Discussion: Deal-Making & Acquisition Drivers in the Next Wave of Cell Therapy”.
1–3 Dec 2026Philadelphia, United States of America
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Tom Thomas, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].